Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation

Anesthesia and Analgesia

Volumn 99, Issue 2, 2004, Pages 353-356

  Planinsic, Raymond M ^a   Nicolau Raducu, Ramona ^a   Eghtesad, Bijan ^a   Marcos, Amadeo ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIFIBRINOLYTIC AGENT; HEPARIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DEATH; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; HYPERCOAGULABILITY; INFERIOR CAVA VEIN; INTRACARDIAC THROMBOSIS; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBECTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 3242770468     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000112318.76543.7C     Document Type: Article

References (16)

1. Gologorsky E, De Wolf AM, Scott V, et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 2001;7:783-9.
2. Fitzsimons MG, Peterfreund RA, Raines DE. Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. Anesth Analg 2001;92:1418-21.
3. O'Connor CJ, Roozeboom D, Brown R, Tuman KJ. Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drug and novel treatment options. Anesth Analg 2000;91:296-9.
4. Sopher M, Braunfeld M, Shackleton C, et al. Fatal pulmonary embolism during liver transplantation. Anesthesiology 1997;87:429-32.
5. Morris PE, Duncan Hite R, Ohl C. Relationship between the inflammation and coagulation pathways in patients with severe sepsis: implications for therapy with activated protein C. Bio-Drugs 2002;16:403-17.
6. Cheema SPS, Webster NR, Dunn F, Bellamy MC. Mediators of fibrinolysis in orthotopic liver transplantation. Clin Transplant 1996;10:24-7.
7. Kettner SC, Gonano C, Seebach F, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998;86:691-5.
8. Tai NRM, Atwal AS, Hamilton G. Modern management of pulmonary embolism. Br J Surg 1999;86:853-68.
9. DeWolf AM, Ramsey G, Teruya J, et al. Hypercoagulability and pulmonary thromboembolism (PE) during liver transplantation (LTX): what is the role of heparin administration? Liver Transpl Surg 2001;7:C-5 (18).
10. DeWolf AM, Ramsey G, Teruya J, et al. Hypercoagulability and pulmonary thromboembolism during liver transplantation: what is the role of heparin administration? Liver Transpl Surg 2003;9:C-40 (157).
11. Kohler M. Antithrombin (AT) substitution: sense or nonsense? Anaesthesia 1998;53:52-4.
12. Haynes G, Lazarchick J, Palesch Y, et al. Antithrombin III activity associated with disseminated intravascular coagulation in orthotopic liver transplantation. Anesthesiology 1998;89:412A.
13. Hong J, Larsson A, Nilsson Ekdahl K, et al. Contact between a polymer and whole blood: sequence of events leading to thrombin generation. J Lab Clin Med 2001;138:139-45.
14. Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure. Kidney Int Suppl 1999;72:S62-6.
15. Mudaliar JH, Liem TK, Nichols WK, et al. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. J Vascular Surgery 2001;34:17-20.
16. Saner F, Hertl M, Broelsch CE. Anticoagulation with hirudin for continuous veno-venous hemodialysis in liver transplantation. Acta Anaesthesiol Scand 2001;45:914-8.